First American Trust’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.4M | Buy |
66,183
+3,974
| +6% | +$882K | 0.97% | 25 |
|
|
2025
Q4 | $14.2M | Buy |
62,209
+3,413
| +6% | +$777K | 0.98% | 23 |
|
|
2025
Q3 | $13.6M | Buy |
58,796
+747
| +1% | +$152K | 0.99% | 27 |
|
|
2025
Q2 | $10.8M | Buy |
58,049
+819
| +1% | +$152K | 0.86% | 28 |
|
|
2025
Q1 | $12M | Buy |
57,230
+2,738
| +5% | +$532K | 1.1% | 21 |
|
|
2024
Q4 | $9.68M | Sell |
54,492
-2,205
| -4% | -$405K | 0.97% | 32 |
|
|
2024
Q3 | $11.2M | Buy |
56,697
+19,967
| +54% | +$3.73M | 1.11% | 26 |
|
|
2024
Q2 | $6.3M | Buy |
36,730
+2,526
| +7% | +$418K | 0.63% | 55 |
|
|
2024
Q1 | $6.23M | Buy |
34,204
+32,166
| +1,578% | +$5.54M | 0.65% | 57 |
|
|
2023
Q4 | $316K | Buy |
+2,038
| New | +$297K | 0.04% | 148 |
|
|
2022
Q4 | – | Sell |
-1,780
| Closed | -$239K | – | 154 |
|
|
2022
Q3 | $239K | Sell |
1,780
-388
| -18% | -$55.7K | 0.04% | 136 |
|
|
2022
Q2 | $332K | Sell |
2,168
-504
| -19% | -$77K | 0.05% | 131 |
|
|
2022
Q1 | $433K | Buy |
2,672
+788
| +42% | +$114K | 0.06% | 116 |
|
|
2021
Q4 | $255K | Buy |
1,884
+2
| +0.1% | +$236 | 0.03% | 147 |
|
|
2021
Q3 | $203K | Buy |
1,882
+67
| +4% | +$7.66K | 0.03% | 152 |
|
|
2021
Q2 | $204K | Buy |
+1,815
| New | +$204K | 0.03% | 149 |
|
|
2021
Q1 | – | Sell |
-2,004
| Closed | -$215K | – | 150 |
|
|
2020
Q4 | $215K | Buy |
+2,004
| New | +$193K | 0.04% | 141 |
|
|
2019
Q3 | – | Sell |
-3,055
| Closed | -$222K | – | 122 |
|
|
2019
Q2 | $222K | Sell |
3,055
-228
| -7% | -$17.9K | 0.05% | 114 |
|
|
2019
Q1 | $264K | Sell |
3,283
-25,170
| -88% | -$2.06M | 0.06% | 98 |
|
|
2018
Q4 | $2.62M | Sell |
28,453
-1,477
| -5% | -$130K | 0.66% | 55 |
|
|
2018
Q3 | $2.83M | Sell |
29,930
-11,725
| -28% | -$1.11M | 0.63% | 56 |
|
|
2018
Q2 | $3.86M | Buy |
41,655
+3,570
| +9% | +$349K | 0.91% | 41 |
|
|
2018
Q1 | $3.6M | Buy |
38,085
+34,519
| +968% | +$3.79M | 0.88% | 41 |
|
|
2017
Q4 | $344K | Hold |
3,566
| – | – | 0.08% | 95 |
|
|
2017
Q3 | $317K | Sell |
3,566
-1,255
| -26% | -$95.5K | 0.08% | 91 |
|
|
2017
Q2 | $349K | Buy |
4,821
+1,300
| +37% | +$87.4K | 0.1% | 89 |
|
|
2017
Q1 | $230K | Sell |
3,521
-200
| -5% | -$12.6K | 0.07% | 98 |
|
|
2016
Q4 | $233K | Buy |
3,721
+361
| +11% | +$22K | 0.07% | 97 |
|
|
2016
Q3 | $211K | Hold |
3,360
| – | – | 0.07% | 105 |
|
|
2016
Q2 | $208K | Buy |
+3,360
| New | +$205K | 0.07% | 99 |
|
|
2014
Q4 | – | Sell |
-4,391
| Closed | -$254K | – | 90 |
|
|
2014
Q3 | $254K | Buy |
4,391
+270
| +7% | +$15K | 0.09% | 87 |
|
|
2014
Q2 | $232K | Buy |
+4,121
| New | +$216K | 0.09% | 83 |
|
Other funds holding ABBV
VCM
VPM
First American Trust's ABBV Position: Q1 2026 in Review
First American Trust increased its AbbVie (ABBV) stake by 6.4% in Q1 2026, buying an estimated $882K and bringing the position to 66,183 shares worth $14.4M. The position accounts for 0.97% of the portfolio, ranked #25.
First American Trust first reported a position in ABBV in Q2 2014 and has held it in 32 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- First American Trust held 66,183 shares of AbbVie worth $14.4M as of Q1 2026.
- First American Trust bought 3,974 AbbVie shares in Q1 2026, an estimated $882K.
- AbbVie made up 0.97% of First American Trust's portfolio in Q1 2026, its #25 holding.
- First American Trust first reported a position in AbbVie in Q2 2014 and has held it in 32 quarters since.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on First American Trust's 13F filing for Q1 2026, filed 12 May 2026.